| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 01/19/2006 | WO2004113297A3 Aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/19/2006 | US20060014948 e.g 1-[3,5-bis(trifluoromethyl)benzoyl]-2-[3-[(2-methoxyethoxy)-methoxy]-4-methylbenzyl]-4-[2-[(3R)-3-methoxymethyl-morpholino]ethyl]piperazine; treating or preventing Tachykinin-mediated diseases in humans or animals |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014817 CCK-1 receptor modulators |
| 01/19/2006 | US20060014816 such as: 3-{5-[3-(2-methoxyethoxy)-1-propynyl]-3-thienyl}-6-[(4-methyl-1-piperazinyl)methyl]-1,4-dihydroindeno[1,2-c]pyrazole; diseases resulting from inappropriate activation of the immune system (e.g., autoimmune disorders), allograft rejection, and graft vs. host disease |
| 01/19/2006 | US20060014803 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 01/19/2006 | US20060014797 [2-(2-Dimethylamino-ethyl)-benzo[b]thiophen-3-yl]-(4-fluoro-phenyl)-methanone; for inhibiting one or more histamine receptors, such as the histamine H1 receptor; improved selectivity, a quicker onset of action, a shorter half-life and/or the ability to penetrate the CNS |
| 01/19/2006 | US20060014794 CXCR1 and CXCR2 chemokine antagonists |
| 01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
| 01/19/2006 | US20060014789 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders |
| 01/19/2006 | US20060014756 Benzimidazoles |
| 01/19/2006 | US20060014755 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/19/2006 | US20060014749 (R)-2-{4-[(1H-Indol-2-ylmethyl)-amino]-piperidin-1-yl}-1-(6-methoxyquinolin-4-yl)-ethanol; effective against both gramnegative and grampositive bacteria |
| 01/19/2006 | DE102004031323A1 Substituierte Pyridazincarboxamide und Derivate hiervon And derivatives thereof substituted Pyridazincarboxamide |
| 01/19/2006 | DE102004023332A1 Chinoxalin-2-on-derivate, diese enthaltende nutzpflanzenschützende Mittel und Verfahren zu ihrer Herstellung und deren Verwendung Quinoxalin-2-one derivatives, useful-plant-protecting compositions containing them and processes for their preparation and their use |
| 01/19/2006 | CA2573380A1 Amide derivatives as inhibitors of histone deacetylase |
| 01/19/2006 | CA2571750A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/19/2006 | CA2571748A1 2, 4, 6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 01/18/2006 | EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 01/18/2006 | EP1616862A1 Nitrogenous heterocyclic compound and use thereof |
| 01/18/2006 | EP1615915A1 Phenacyl 2-hydroxy-3-diaminoalkanes |
| 01/18/2006 | EP1615907A1 5-amino-2-carbonylthiophene derivatives for use as p38 map kinase inhibitors in the treatment of inflammatory diseases |
| 01/18/2006 | EP1615905A2 Benzopyran compounds useful for treating inflammatory conditions |
| 01/18/2006 | EP1615898A1 2-aminopyrimidine derivatives and their medical use |
| 01/18/2006 | EP1615895A1 Biaryl substituted pyrazoles as sodium channel blockers |
| 01/18/2006 | EP1615894A2 3-azabicyclo 3.2.1 octane derivatives |
| 01/18/2006 | EP1615889A2 Biphenyl derivatives having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 01/18/2006 | EP1615886A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions |
| 01/18/2006 | EP1615881A2 Diarylmethyl and related compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity |
| 01/18/2006 | EP1615637A1 Pharmaceutical use of substituted 1,2,4-triazoles |
| 01/18/2006 | EP1615633A2 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 01/18/2006 | EP1615613A2 Quinoxalinyl macrocyclic hepatitis c serine protease inhibitors |
| 01/18/2006 | EP1412338B1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
| 01/18/2006 | EP1194410B1 Benzimidazole derivatives and pharmaceutical compositions comprising these compounds |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1723206A High specificity anticancer pharmacological drug system, drug synthesis, and drug development process |
| 01/18/2006 | CN1723200A (2-carboxamido) (3-amino) thiophene compounds |
| 01/18/2006 | CN1723197A Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
| 01/18/2006 | CN1723196A Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/18/2006 | CN1721498A Fluorescent maleimides and uses thereof |
| 01/18/2006 | CN1721417A New pyrrolidine and thiazolidine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 01/18/2006 | CN1721411A Benzimidazole derivatives as modulators IgE |
| 01/18/2006 | CN1721407A New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 01/18/2006 | CN1720913A Water-soluble triazole fungicide |
| 01/18/2006 | CN1237060C Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 01/18/2006 | CN1237055C 三唑衍生物 Triazole derivatives |
| 01/18/2006 | CN1237054C Insecticidal and acaricidal agents |
| 01/18/2006 | CN1237051C Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/17/2006 | US6987188 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders |
| 01/17/2006 | US6987164 Electrically conductive polymer, sensor using the same, and method for detecting target molecule using the sensor |
| 01/17/2006 | US6987123 A substituted pyrrole-1-yl-alkyloxy-aryl-2-alkyloxypropanoate derivatives, antilipiemic agents, anticholesterol agents |
| 01/17/2006 | US6987110 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 01/17/2006 | US6986952 a main chain that consists of a substituted or non-substituted 2,5-thiophenediyl group, and two substituted or non-substituted 9-carbazolyl groups bonded to each terminal of thiophenediyl ring |
| 01/17/2006 | CA2362394C Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 01/17/2006 | CA2118812C 5-ht4 receptor antagonists |
| 01/12/2006 | WO2006004925A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | WO2006003408A1 Electroluminescent materials and devices |
| 01/12/2006 | WO2006003276A1 Substituted indazoles, compositions containing same, preparation and use |
| 01/12/2006 | WO2006003096A1 Condensed thiophene derivatives and their use as cyclic glp-1 agonists |
| 01/12/2006 | WO2005117908A3 Triheterocyclic compounds compositions, and methods for treating cancer or viral diseases |
| 01/12/2006 | WO2005100320A3 Crystalline 2-amino-3-cyanoquinoline derivatives, process of their preparation and pharmaceutical compositions containing them |
| 01/12/2006 | WO2005092066A3 Imidazole compounds |
| 01/12/2006 | WO2005080343A3 3-substituted 1,5-diphenylpyrazole derivatives useful as cb1 modulators |
| 01/12/2006 | WO2005060959A8 Pyrazole derivatives and use thereof as orexin receptor antagonists |
| 01/12/2006 | US20060009481 Arylindenopyridines and related therapeutic and prophylactic methods |
| 01/12/2006 | US20060009467 Novel gamma secretase inhibitors |
| 01/12/2006 | US20060009461 Acetamides and benzamides that are useful in treating sexual dysfunction |
| 01/12/2006 | US20060009455 especially blood coagulation factor XIa and plasma kallikrein; e.g. 4-aminomethyl-[2-phenyl-1-(4-phenyl-pyridin-2-yl)-ethyl]-trans cyclohexanecarboxamide; anticoagulant, antiinflammatory agent; |
| 01/12/2006 | US20060009453 Protein kinase modulators and method of use |
| 01/12/2006 | US20060009446 New compounds |
| 01/12/2006 | DE102004030099A1 Gesättigte und ungesättigte 3-Pyridyl-benzocycloalkylmethyl-amine als Serotonin- und/oder Noradrenalin-Reuptake-Hemmer und/oder µ-Opioidrezeptor-Modulatoren Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines as serotonin and / or norepinephrine reuptake inhibitor and / or μ-opioid receptor modulators |
| 01/12/2006 | CA2572872A1 Tissue factor production inhibitor |
| 01/12/2006 | CA2572316A1 Imidazolo-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2572084A1 Tetrahydroquinazolin-4(3h)-one-related and tetrahydropyrido[2,3-d]pyrimidin-4(3h)-one-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2567744A1 Substituted indazoles, compositions containing same, preparation and use |
| 01/11/2006 | EP1614688A1 Phenylazole compound, production process, and antioxidant drug |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614676A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 01/11/2006 | EP1614432A2 Method for treating amyloidosis |
| 01/11/2006 | EP1614419A1 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof |
| 01/11/2006 | EP1613634A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase |
| 01/11/2006 | EP1613622A1 Oxime derivatives and their use as pharmaceutically active agents |
| 01/11/2006 | EP1613621A1 Prostaglandin analogs as ep4 receptor agonists |
| 01/11/2006 | EP1613618A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE FOR MODULATING THE GABA- sb A /sb RECEPTOR COMPLEX |
| 01/11/2006 | EP1613613A2 Cxcr4 chemokine receptor binding compounds |
| 01/11/2006 | EP1613612A2 Bioreductively-activated prodrugs |
| 01/11/2006 | EP1613607A1 Benzenesulphonamide derivatives as herbicides or desiccant/defoliant compounds |
| 01/11/2006 | EP1613597A1 6-substituted nicotinamide derivatives as opioid receptor antagonists |
| 01/11/2006 | EP1613322A2 Aminoquinoline compounds |
| 01/11/2006 | EP1613315A1 Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/11/2006 | EP1613313A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
| 01/11/2006 | EP1613303A1 Substituted p-diaminobenzene derivatives |
| 01/11/2006 | EP1613156A1 N-phenyl- " (4-pyridyl)- azinyl!amine derivatives as plant protection agents |
| 01/11/2006 | EP1497283A4 Maleic acid salt of(2s)-n-(5(amino(imino)methyl)-2-thienyl)methyl-1-(2r)-2-((2r)-2-((carboxymethyl)amino)3,3-diphenylpropanoyl)-2-pyrrolidine carboxamide and a process for |
| 01/11/2006 | CN1720245A Oxime ester photoinitiators with heteroaromatic groups |
| 01/11/2006 | CN1720244A Anthranilic acid amide derivatives and their pharmaceutical use |
| 01/11/2006 | CN1720234A Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives |
| 01/11/2006 | CN1720233A Pesticidal sulphonylaminopyrazoles |